Clinical evaluation of a new anorexigenic drug, aminoxaphen, in obese diabetics.
D000328:Adult; D001067:Appetite Depressants / Q000009:adverse effects / Q000627:therapeutic use*; D002784:Cholesterol; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004802:Eosinophilia / Q000209:etiology; D005260:Female; D005767:Gastrointestinal Diseases / Q000209:etiology; D006801:Humans; D008297:Male; D008593:Menopause; D009765:Obesity; D010919:Placebos; D013276:Stomach Ulcer / Q000209:etiology; D014527:Uric Acid / Q000378:metabolism
D001067:Appetite Depressants; D010919:Placebos; D014527:Uric Acid; D002784:Cholesterol